Aligos

formerly Aligos TherapeuticsIPO

Home - ALIGOS Therapeutics

Aligos was founded in 2018, is headquartered in South San Francisco, United States, lists 51–200 employees, and has $230.0M in recorded funding across 2 rounds.

Employees
51–200
Founded
2018
Website
aligos.com
Total Funding
$230.0M
Last Round
$105.0M Venture RoundFeb 2025
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Aligos is a clinical-stage biotechnology company developing therapies for liver and viral diseases. Its science-driven pipeline addresses high unmet-need conditions including chronic hepatitis B virus infection and metabolic dysfunction-associated steatohepatitis (MASH). The company applies hepatology and virology expertise to advance purpose-built drug candidates intended to improve patient outcomes.

Summary

Aligos is a Biotech company based in South San Francisco, United States, founded in 2018. It lists 51–200 employees. It has raised $230.0M in total across 2 rounds, most recently a $105.0M Venture Round in Feb 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Venture RoundPrivate Placement FinancingFeb 2025
$105.0M

Sign up to see all 3 events

Funding: Series B through Venture Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aligos on Indexed.vc
<a href="https://indexed.vc/companies/aligos"><img src="https://indexed.vc/api/badge/company/aligos" alt="Aligos on Indexed.vc" width="260" height="76" /></a>